No abstract available
Publication types
-
Clinical Trial, Phase III
-
Multicenter Study
-
Randomized Controlled Trial
MeSH terms
-
Adult
-
Aged
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / administration & dosage
-
Chemotherapy, Adjuvant / methods
-
Cystectomy / methods*
-
Disease-Free Survival
-
Female
-
Germany
-
Humans
-
Male
-
Middle Aged
-
Muscle, Smooth / pathology
-
Neoplasm Invasiveness
-
Risk Factors
-
Survival Rate
-
Treatment Outcome
-
Urinary Bladder Neoplasms / diagnosis
-
Urinary Bladder Neoplasms / pathology*
-
Urinary Bladder Neoplasms / therapy*
-
Watchful Waiting / methods*
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
atezolizumab